Sprint Bioscience AB (SPRINT) — Capital Reinvestment Ratio
Latest as of December 2025:
0.00x
Sprint Bioscience AB (SPRINT) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow (Skr115.84 Million) in capital expenditures (Skr65.00K). See SPRINT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
Skr115.84 Million
SEK
Capital Expenditures
Skr65.00K
SEK
Data as of
Dec 2025
Most recent filing
Sprint Bioscience AB Capital Reinvestment Ratio (2015–2025)
This chart tracks Sprint Bioscience AB's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Sprint Bioscience AB (2015–2025)
Year-by-year Capital Reinvestment Ratio for Sprint Bioscience AB from 2015 to 2025. For live market cap and broader valuation context, see market value of Sprint Bioscience AB.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | Skr83.53 Million | Skr94.00K | ▼ -99.0% |
| 2023 | 0.11x | Skr22.87 Million | Skr2.45 Million | ▼ -91.4% |
| 2016 | 1.25x | Skr7.93 Million | Skr9.91 Million | ▼ -83.2% |
| 2015 | 7.43x | Skr833.54K | Skr6.19 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow